Miguel Arcángel Vázquez-Padua

• Established five strategic partnerships including BlueCloud, Medinexo, and Partners for Patients (Switzerland) to develop new clinical trial centers and foster Centers of Excellence in Clinical Research in underrepresented communities
• Managed proof of concept clinical trial for new emerging company (Magic Lifesciences, Inc.) in collaboration with Medinexo
• Negotiated clinical trial budgets and contracts
• Developed clinical programs to reduce hospital readmissions.

• Created, developed and implemented theOffice of Clinical Trials
• Launched new pharmaceutical industry-sponsored clinical trials at UPRCCC with contracts over $5.5MM.

• Developed corporate targets, standards, KPIs, and performance goals in the health IT segment.
• Implemented 25 corporate standard operating processes, including a new organizational structure.
• Delivered CCM EMR (Chronic Care Management, Electronic Medical Record) enhancements to twelve different medical practices in New York and New Jersey.

• Led the implementation of the Clinical Programs Unit to develop new initiatives to improve patient outcomes and reduce costs
• Evaluated programs for palliative care with external contractors.
• Initiated and managed team of five (5) members from different areas into one cohesive and diverse team.

• Established new business relationships with sponsors in the Pharmaceutical and Medical Devices industry, including contracts and budget negotiations
• On boarded five (5) new clinical trial sites, including a preferred site for a major pharmaceutical company
• Secured a grant from the Economic Development and Commerce funded by the US Workforce Innovation and Opportunity Act (WIOA)
• Co-authored one successful grant application for the first Telemedicine Infrastructure Grant for the Puerto Rico Science, Technology and Research Trust.

• Led planning and implementation of Medicaid Line of Business, expanding clinical staff and creating new processes, policies, and training
• Implemented organization-wide patient-centric electronic platform (MedHOk)
• Oversaw delegated services with various entities
• Led the clinical affairs team in response to Hurricane Maria
• Managed clinical affairs department with over 200 employees

• Led commercial business unit for General Pharma in Puerto Rico and US Virgin Islands and further developed its commercial execution culture
• Achieved sales goals for respiratory, cardiovascular/metabolic, and urology product portfolios
• Successfully launched three (3) new products: Breo Ellipta, Anoro Ellipta, Tanzeum
• Implemented new performance evaluation and incentive system

State Director-Country Lead, Dec 2009 to March 2013

• Led the reorganization of the commercial operations of Pfizer for Puerto Rico and the Caribbean
• Managed changes in personnel and integration of assets from King Pharmaceuticals and Wyeth
• Achieved and exceeded sales goals for three consecutive years.

Clinical Director, Medical & Regulatory Affairs Department, Aug 2005 to Dec 2009

• Expanded and developed an integrated Medical and Regulatory Affairs department
• Increased the number of active clinical trials and researchers in Puerto Rico
• Supported new product launches: Selzentry, Sutent, and Eraxis
• Successfully completed the first internal global audit of the department

Senior Regional Medical and Regulatory Specialist, US Medical, April 2003 to July 2005

• Developed relationships with Key Opinion Leaders and Researchers in the Caribbean,and implemented advisory boards
• Started Pfizer-sponsored public health programs
• Supported new product launches: Caduet, Lyrica, Exubera, and Macugen

Senior Clinical Sciences Manager, Pharmacia Legacy, May 2001 to April 2003

• Supported branded and unbranded initiatives for the Pharmacia portfolio
• Supported new product launches: Bextra, Dynastat, Axert

• Implemented and negotiated three (3) clinical research projects and established new plans for clinical trials in Puerto Rico in HIV, Neurology, Asthma, and Psychiatry.

• Provided medical support to four (4) new product launches in CNS, Oncology, Rheumatology, and Diabetes.

• Led Department of Anatomy and Cell Biology
• Conducted research projects in biochemical pharmacology funded by NIH
• Lecturer in Pharmacology, Biochemistry, and Cell and Molecular Biology
• Actively participated in steering committee for re-accreditation of School of Medicine